摘要
子宫肌瘤合并乳腺增生病为生育期女性常见疾病,因二者生理、病理的相关性,发病率逐年上升,目前现代医学对二者起共同治疗作用的药物较少,主要有甲孕酮、三苯氧胺、维生素E,虽有一定疗效,但因其不能忽视的副作用使其用药的局限性增加,而中医药因其辨证的整体性,治疗的个体化及疗效的确切性,在子宫肌瘤合并乳腺增生病的治疗上更凸显了优势,但尚存在不足,亟待未来在子宫肌瘤合并乳腺增生病的中医药治疗上有进一步的突破。
Hysteromyoma merger hyperplasia is common diseases of mammary glands of women of child-bearing period.It was due to both physiological and pathological relevance,the incidence increased year by year.Modern medicine is a common treatment effect on the role of the two drugs less.There is a progesterone,tamoxifen,vitamin E,although a certain effect,but can not be ignored because of their side-effects of the limitations of its use to increase,and differentiation of Chinese medicine because of its holistic,individualized treatment and efficacy of the exact nature to trent the uterine muscle hyperplasia of mammary gland tumor.Its more highlights the advantages,but still less than needed in the future.It was needed further breakthrough in treting hysteromyoma merger hyperplasia of mammary glands in Chinese medicine.
出处
《中医学报》
CAS
2010年第1期34-36,共3页
Acta Chinese Medicine
基金
江苏省科技厅基金项目(编号:BS2002324)
关键词
子宫肌瘤
乳腺增生病
中医药
诊治
hysteromyoma
mammary glands
Chinese medicine
diagnosis and treatment
